# XC8 in the Treatment of Patients With Bronchial Asthma

> **NCT03450434** · PHASE2 · COMPLETED · sponsor: **PHARMENTERPRISES LLC** · enrollment: 120 (actual)

## Conditions studied

- Bronchial Asthma

## Interventions

- **DRUG:** XC8 Oral Tablet
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT03450434
- **Lead sponsor:** PHARMENTERPRISES LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09-20
- **Primary completion:** 2017-09-27
- **Final completion:** 2017-09-27
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2018-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03450434

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03450434, "XC8 in the Treatment of Patients With Bronchial Asthma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03450434. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*